keyword
https://read.qxmd.com/read/38652681/engineered-cell-membrane-coated-nanoparticles-new-strategies-in-glioma-targeted-therapy-and-immune-modulation
#1
REVIEW
Yilei Ma, Jia Yi, Jing Ruan, Jiahui Ma, Qinsi Yang, Kun Zhang, Maolan Zhang, Guoming Zeng, Libo Jin, Xiaobei Huang, Jianshu Li, Haifeng Yang, Wei Wu, Da Sun
Gliomas, the most prevalent primary brain tumors, pose considerable challenges due to their heterogeneity, intricate tumor microenvironment (TME), and blood-brain barrier (BBB), which restrict the effectiveness of traditional treatments like surgery and chemotherapy. This review provides an overview of engineered cell membrane technologies in glioma therapy, with a specific emphasis on targeted drug delivery and modulation of the immune microenvironment. This study investigates the progress in engineered cell membranes, encompassing physical, chemical, and genetic alterations, to improve drug delivery across the BBB and effectively target gliomas...
April 23, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38652518/is-a-low-dose-of-dexamethasone-sufficient-to-prevent-paclitaxel-related-hypersensitivity-reactions-a-retrospective-study-in-patients-with-gynecologic-malignancy
#2
JOURNAL ARTICLE
Di Xiao, Zhiyun Yang, Yin Shi, Wenqing Yang, Yu Zhang
BACKGROUND: Paclitaxel hypersensitivity reactions (HSRs) are prevalent, especially in females. The common paclitaxel pretreatment, dexamethasone, may inhibit chemotherapy efficacy and accelerate tumor progression. We aimed to balance paclitaxel HSRs and the lowest dexamethasone dose for gynecologic malignancies. METHODS: We retrospectively examined 1,074 cycles of 3-weekly paclitaxel-containing treatment for 231 gynecologic malignancies at Xiangya Hospital. HSR incidence with different dexamethasone regimens was the primary outcome...
April 23, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38652426/antibody-drug-conjugates-in-urological-cancers-a-review-of-the-current-landscape
#3
REVIEW
Aruni Ghose, Patricia Lapitan, Vedika Apte, Adheesh Ghosh, Abhinav Kandala, Sreejana Basu, Jo Parkes, Sayali D Shinde, Stergios Boussios, Anand Sharma, Prantik Das, Nikhil Vasdev, Sara E Rebuzzi, Yüksel Ürün, Ravindran Kanesvaran, Akash Maniam, Giuseppe L Banna
PURPOSE OF REVIEW: Our review delves into the progress across urological malignancies and discusses ongoing challenges and future directions in antibody-drug conjugate (ADC) development, emphasising their transformative potential in cancer care. RECENT FINDINGS: ADCs have advanced from hematologic to solid tumours, notably in breast cancer, and are now pivotal in metastatic urological cancers as both monotherapies and in combination regimens, underscored by the FDA's approval of enfortumab vedotin and sacituzumab govitecan for metastatic urothelial cancer...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652406/ferroptosis-is-an-effective-strategy-for-cancer-therapy
#4
REVIEW
Afrasyab Khan, Yu Huo, Yilei Guo, Juanjuan Shi, Yongzhong Hou
Ferroptosis is a form of intracellular iron-dependent cell death that differs from necrosis, autophagy and apoptosis. Intracellular iron mediates Fenton reaction resulting in lipid peroxidation production, which in turn promotes cell death. Although cancer cell exhibit's ability to escape ferroptosis by multiple pathways such as SLC7A11, GPX4, induction of ferroptosis could inhibit cancer cell proliferation, migration and invasion. In tumor microenvironment, ferroptosis could affect immune cell (T cells, macrophages etc...
April 23, 2024: Medical Oncology
https://read.qxmd.com/read/38652344/comprehensive-review-of-the-repositioning-of-non-oncologic-drugs-for-cancer-immunotherapy
#5
REVIEW
Abdur Rauf, Payal B Joshi, Ahmed Olatunde, Nabia Hafeez, Zubair Ahmad, Hassan A Hemeg, Abdullah S M Aljohani, Waleed Al Abdulmonem, Muthu Thiruvengadam, Dhivya Viswanathan, Govindasamy Rajakumar, Rekha Thiruvengadam
Drug repositioning or repurposing has gained worldwide attention as a plausible way to search for novel molecules for the treatment of particular diseases or disorders. Drug repurposing essentially refers to uncovering approved or failed compounds for use in various diseases. Cancer is a deadly disease and leading cause of mortality. The search for approved non-oncologic drugs for cancer treatment involved in silico modeling, databases, and literature searches. In this review, we provide a concise account of the existing non-oncologic drug molecules and their therapeutic potential in chemotherapy...
April 23, 2024: Medical Oncology
https://read.qxmd.com/read/38652119/long-term-remission-after-upfront-autologous-hematopoietic-stem-cell-transplant-for-cd5-diffuse-large-b-cell-lymphoma
#6
JOURNAL ARTICLE
Yosuke Masamoto, Akira Honda, Aya Shinozaki-Ushiku, Tetsuo Ushiku, Mineo Kurokawa
CD5+ diffuse large B-cell lymphoma (DLBCL) is a rare subtype characterized by an inferior outcome. While dose-dense therapy shows promising activity, the optimal management remains to be determined. To evaluate the benefit of consolidative autologous hematopoietic stem cell transplantation (ASCT), we retrospectively reviewed the medical records of 47 consecutive patients with newly diagnosed de novo CD5+ DLBCL. Of 19 patients ≤ 70 of age with age-adjusted International Prognostic Index 2-3, eight underwent upfront ASCT, and nine did not, despite preserved organ function and response after induction therapy...
April 23, 2024: Journal of Chemotherapy
https://read.qxmd.com/read/38652046/shikonin-in-breast-cancer-treatment-a-comprehensive-review-of-molecular-pathways-and-innovative-strategies
#7
JOURNAL ARTICLE
Saeid Iranzadeh, Davood Dalil, Soroush Kohansal, Mahdi Isakhani
OBJECTIVES: Breast cancer is a prevalent disease that has a substantial impact on women's mortality rates. Shikonin, a naphthoquinone derived from Lithospermum erythrorhizon, has demonstrated substantial anticancer effects. This study aims to conduct a comprehensive review of the latest research findings regarding the therapeutic efficacy of shikonin in the context of breast cancer treatment, with a specific emphasis on elucidating the underlying molecular mechanisms. METHODS: A comprehensive literature review was conducted on shikonin and breast cancer by searching PubMed, Scopus, Web of Science, and Google Scholar databases...
April 23, 2024: Journal of Pharmacy and Pharmacology
https://read.qxmd.com/read/38651681/fulfilling-the-role-of-a-parent-while-undergoing-treatment-for-cancer-a-review-of-the-literature-and-the-potential-impact-of-childcare-support-on-cancer-outcomes
#8
JOURNAL ARTICLE
Kang Woo Kim, Mary Lopresti, Stephanie L Graff, Sabrina Witherby, Don S Dizon, Mary Anne Fenton
Breast cancer is the most prevalent malignancy among adolescents and young adults (AYAs). Despite the efficacy of chemotherapy, AYA patients contend with psychosocial challenges, including psychological distress and financial toxicity, exacerbated further by those with dependent children. Parenting responsibilities intersect with cancer care, impacting both family dynamics and treatment adherence. Despite recognized needs, however, the impact of parenting concerns or even parenting status and the presence of dependents has not been systematically addressed and there is a paucity of interventional research regarding patients with cancer as concomitant caregivers...
April 23, 2024: American Journal of Clinical Oncology
https://read.qxmd.com/read/38651346/effectiveness-of-nasolacrimal-scc-treatments-and-promising-role-of-chemo-induction-a-case-report-and-systematic-review
#9
REVIEW
Mohammad Bilal Alsavaf, Moataz D Abouammo, Govind S Bhuskute, Shuai Sun, Majd Issa, Nolan B Seim, Kyle K VanKoevering, Priyanka Bhateja, Marcelo Bonomi, Ricardo L Carrau
OBJECTIVE: To comprehensively analyze reported cases of nasolacrimal squamous cell carcinoma (NLSCC), focusing on risk factors, treatment modalities, and outcomes. Additionally, investigate the impact of human Papillomavirus (HPV) status and histopathological subtypes' impact on prognosis. DATA SOURCES: Pubmed, Embase. REVIEW METHODS: We conducted a systematic literature review to identify relevant studies reporting cases of NLSCC. The review methods adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines...
April 23, 2024: Laryngoscope
https://read.qxmd.com/read/38651280/hepatic-artery-infusion-chemotherapy-combined-with-the-folfox-regimen-for-the-treatment-of-hepatocellular-carcinoma-recent-advances-and-literature-review
#10
REVIEW
Suqi Zhu, Yahan Yu, Mingqi Yang, Xin Liu, Mingkai Lai, Jieren Zhong, Xiaoguang Zhao, Ligong Lu, Yanyan Liu
INTRODUCTION: The incidence of primary liver cancer (PLC) has experienced a significant global increase, primarily attributed to the rise in hepatocellular carcinoma (HCC). Unfortunately, HCC is often diagnosed in advanced stages, leaving patients with limited treatment options. Therefore, transformation therapy is a crucial approach for long-term survival and radical resection in patients with advanced HCC. Conversion therapy has demonstrated promise in the treatment of advanced HCC...
April 23, 2024: Expert Review of Anticancer Therapy
https://read.qxmd.com/read/38651235/custom-design-of-multi-stimuli-responsive-degradable-silica-nanoparticles-for-advanced-cancer-specific-chemotherapy
#11
REVIEW
Junjie Zhang, Jiani Zhou, Longguang Tang, Jiayi Ma, Ying Wang, Hui Yang, Xiaoxiao Wang, Wenpei Fan
Chemotherapy is crucial in oncology for combating malignant tumors but often encounters obatacles such as severe adverse effects, drug resistance, and biocompatibility issues. The advantages of degradable silica nanoparticles in tumor diagnosis and treatment lie in their ability to target drug delivery, minimizing toxicity to normal tissues while enhancing therapeutic efficacy. Moreover, their responsiveness to both endogenous and exogenous stimuli opens up new possibilities for integrating multiple treatment modalities...
April 23, 2024: Small
https://read.qxmd.com/read/38651152/regional-intra-arterial-vs-systemic-chemotherapy-for-the-treatment-of-advanced-pancreatic-cancer-a-systematic-review-and-meta-analysis
#12
Yanjie Cao, Dedong Yu, Yun Wu, Wei Zhu
INTRODUCTION: Pancreatic cancer is a highly aggressive malignancy with limited response to chemotherapy. This research aims to compare the effectiveness and safety of regional intra-arterial chemotherapy (RIAC) with conventional systemic chemotherapy in treating advanced stages of pancreatic cancer. METHODS: A comprehensive literature review was conducted using databases such as PubMed, Embase, Web of Science, and the Cochrane Library. Studies assessing the comparative outcomes of RIAC and systemic chemotherapy were included...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38650920/second-line-treatment-of-pancreatic-adenocarcinoma-shedding-light-on-new-opportunities-and-key-talking-points-from-clinical-trials
#13
REVIEW
Robin Imperial, Osama Mosalem, Umair Majeed, Nguyen H Tran, Mitesh J Borad, Hani Babiker
Despite improvements in overall cancer mortality, deaths related to pancreatic cancer continue to rise. Following first-line treatment, second-line options are significantly limited. Classically, first-line treatment consisted of either gemcitabine or 5-fluorouracil based systemic chemotherapy. Upon progression of disease or recurrence, subsequent second-line treatment is still gemcitabine or 5-fluorouracil based chemotherapy, depending on what was used in the first line and the timing of progression or recurrence...
2024: Clinical and Experimental Gastroenterology
https://read.qxmd.com/read/38650799/malignancy-associated-secondary-hemophagocytic-lymphohistiocytosis-mimicking-an-infection-a-case-report-and-review-of-the-literature
#14
Meenakshi Gopalakrishnan, Arunalini Ramanathan, Dhaarani Jayaraman, Sri Gayathri Shanmugam, Julius Xavier Scott
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hematological disorder of immune dysregulation associated with significant challenges in diagnosis and management. Described as primary HLH secondary to genetic defects or more commonly secondary to infections, it can also occur secondary to malignancy, i.e., malignancy-associated hemophagocytic lymphohistiocytosis (M-HLH). A five-year-old male child presented with left cervical adenopathy and a high-spiking fever for two weeks. He had pallor, anasarca, multiple enlarged and matted cervical lymph nodes, respiratory distress, and hepatomegaly...
March 2024: Curēus
https://read.qxmd.com/read/38650771/type-b-lactic-acidosis-a-very-rare-but-fatal-complication-of-gastrointestinal-solid-tumor
#15
Fuad I Abaleka, Genanew Bedanie, Diego Olavarria Bernal, Selome F Yewedalsew, Tasur Seen
Type B lactic acidosis, secondary to solid cancer, is very rare. It is mostly seen in patients with hematological malignancies. Although its exact pathogenesis is unknown, it is believed to be caused by overproduction and the inability of tumor cells to remove lactate. In the last 26 years, a systematic review of the literature only identified two previous reports of colorectal cancer-related type B lactic acidosis. Here, we report the third case of severe type B lactic acidosis due to stage IV colorectal with liver metastasis...
March 2024: Curēus
https://read.qxmd.com/read/38650534/future-perspectives-of-radiation-therapy-for-hodgkin-lymphoma-risk-adapted-response-adapted-and-safer-than-before
#16
REVIEW
Jessica Saddi, Amelia Barcellini, Manuel Gotti, Alessandro Mazzacane, Alessandra Tolva, Tanja Lazic, Luca Arcaini, Marco Zecca, Ester Orlandi, Andrea Riccardo Filippi
Classical Hodgkin lymphoma is a lymphoproliferative disease with a good prognosis mainly seen in young people. Nevertheless secondary malignancy, cardiac disease and infertility may affect the long survivors with significant impact on quality of life, morbidity and overall survival. In the last decades several treatment strategies were evaluated to reduce the toxicity of first line treatment such as avoiding radiotherapy or its reduction in terms of dosage and extension. Many trials including interim Positron Emission Tomography evaluation fail to compare efficacy between combined modality treatment versus chemotherapy alone in particular in early stage disease...
May 2024: Hematological Oncology
https://read.qxmd.com/read/38650415/-testicular-involvement-in-pediatric-lymphoid-tumors-a-review-of-the-literature-and-a-series-of-clinical-observation
#17
JOURNAL ARTICLE
S Korneeva M, A Batmanova N, R Panferova T, T Valiev T
Lymphoid tumors with testicular involvement in childhood are rare and heterogeneous. The disease may manifest with uni- or bilateral scrotal enlargement. Comprehensive examination includes evaluation of all lymph nodes involvement, as well as ultrasound examination, magnetic resonance imaging and positron emission tomography. A diagnosis is made on basis of morphological and immunohistochemical verification. Determination of lymphoid tumor variant and stage, is recommended to perform chemotherapy according to prognostic risk group, and, in some cases, transplantation of hematopoietic stem cells is required as consolidation therapy...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38649941/surgical-management-of-renal-cell-carcinoma-with-subhepatic-inferior-vena-cava-tumor-thrombus-a-case-report-and-review-of-the-literature
#18
JOURNAL ARTICLE
Bekim Ademi, Luan Jaha, Isa Haxhiu, Xhevdet Çuni, Afrim Tahiri, Jetmir Gashi, Adhurim Koshi, Art Jaha
BACKGROUND: Renal cell carcinomas are the most common form of kidney cancer in adults. In addition to metastasizing in lungs, soft tissues, bones, and the liver, it also spreads locally. In 2-10% of patients, it causes a thrombus in the renal or inferior vena cava vein; in 1% of patients thrombus reaches the right atrium. Surgery is the only curative option, particularly for locally advanced disease. Despite the advancements in laparoscopic, robotic and endovascular techniques, for this group of patients, open surgery continues to be among the best options...
April 23, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38649498/-current-developments-in-the-treatment-of-neuroendocrine-tumors
#19
REVIEW
Barbara Kiesewetter-Wiederkehr, Philipp Melhorn, Christian Scheuba, Markus Raderer
BACKGROUND: Well-differentiated neuroendocrine tumors (NET) are rare malignancies that are clinically very heterogeneous. Accordingly, their treatment is also complex and dependent on various factors. With currently available systemic therapies, the prognosis is often favorable. OBJECTIVES: This article aims to provide an overview of current treatment strategies for NET, addressing the most important NET locations. METHODS: The current European guidelines and further relevant literature on the treatment of NET were reviewed for this purpose...
April 22, 2024: Radiologie (Heidelb)
https://read.qxmd.com/read/38649011/circrnas-in-cancer-therapy-tolerance
#20
REVIEW
Miao He, Yunyan Pan, Chongge You, Hongwei Gao
The rapidly expanding field of circular RNA (circ-RNA) research has opened new avenues in cancer diagnostics and treatment, highlighting the role of serum circRNAs as potential biomarkers for assessing tumor therapy resistance. This review comprehensively compiles existing knowledge regarding the biogenesis, function, and clinical relevance of circRNAs, emphasizing their stability, abundance, and cell type-specific expression profiles, which make them ideal candidates for noninvasive early biomarkers in cancer treatment...
April 20, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
keyword
keyword
170374
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.